Research Vision & Scope

Research that connects clinic decisions with cardio-metabolic outcomes.

Dr Panda's scholarship connects day-to-day internal-medicine practice with translational work that improves diabetes, hypertension, lipid, and prevention outcomes in India.

July 2026 Snapshot Cardio-metabolic research portfolio
Indexed Papers 44
Citations 320+
Trials 3
Research domain Diabetes therapeutics
Research domain Hypertension in diabetes
Research domain Lipid disorders
Research domain Population prevention
ICMR-GCP IEC Review De-identified Data

Key Metrics July 2026

Research output across publications, citations, guidelines, and trials.

Counts combine PubMed, JAPI, ResearchGate, clinical-trial registry, and society-publication records supplied for this profile.

01 44

Research metric publications

indexed articles

PubMed, JAPI, ResearchGate
02 320+

Research metric citations

citation count

Combined public records
03 11

Research metric h-index

scholarly impact

Research profile data
04 8

Research metric guidelines

API, RSSDI, LAI

Society publications
05 3

Research metric trials

clinical studies

Registries and investigator records

Flagship Multi-Centre Clinical Trials

Investigator roles across national and translational clinical studies.

These studies connect diabetes, respiratory medicine, and metabolic-risk research with practical tertiary-centre and primary-care outcomes.

01
ClinicalTrials.gov

LIRA-PRIME

Liraglutide versus oral antidiabetic drugs in type 2 diabetes primary care.

Registry / ID
NN2211-4232 / NCT02730377
Role
Lead Investigator - Odisha site
Status
Outcome published 2021
02
Phase III, CTRI pending

Triple-Drug Asthma MDI

Multi-centre evaluation of triple-drug inhaled therapy in Indian asthma care.

Registry / ID
Vilanterol + glycopyrronium + fluticasone
Role
National co-investigator
Status
Indian efficacy paper 2025
03
Tertiary-centre survey

Indian Liver-Fibrosis Survey in T2DM

Non-invasive liver-fibrosis burden across tertiary diabetes centres.

Registry / ID
PubMed in-press 2026
Role
Steering member
Status
In press

Guideline & Consensus Contributions

National recommendations for diabetes, hypertension, and dyslipidaemia care.

Dr Panda's consensus work spans API, RSSDI, and LAI contributions, with a focus on translating specialist evidence into Indian clinical practice.

API RSSDI LAI ICP JAPI
  • Management of Hypertension in Patients with Type 2 Diabetes - Indian Guideline 2024 (Association of Physicians of India & ICP)
  • Multispecialty Consensus 2025 on Hypertension Phenotypes & Comorbidities (JAPI, in press)
  • RSSDI Clinical-Practice Recommendations for Type 2 Diabetes - steering committee member (2017-22 updates)
  • RSSDI Consensus on Self-Monitoring of Blood Glucose (2018)
  • Lipid Association of India Consensus on Diabetic Dyslipidaemia (2023)

Recent High-Impact Publications

Latest first, with the full bibliography on Publications.

Open Publications Page
2024

Platform for precise, personalised glucose forecasting through CGM and deep learning

Medical Engineering & Physics

2024

Indian Guideline 2024 on Hypertension in Type 2 Diabetes

JAPI

2023

Position statement - Diabetes technology for public-health outcomes

Journal of Diabetology

2021/22

Maintenance of glycaemic control with liraglutide (LIRA-PRIME outcome)

Diabetes Obesity & Metabolism

Grants & Funding

Cardio-metabolic risk studies and phase-III clinical trials.

Principal or co-investigator on ICMR-funded cardio-metabolic risk studies in Eastern India and multiple industry-sponsored phase-III trials, including liraglutide and triple-drug MDI programmes.

National

AIIMS Bhubaneswar, JIPMER Puducherry, St John's Research Institute, and medical colleges under Odisha University of Health Sciences.

International

Diabetes Technology Network (EU/UK) collaboration on CGM analytics and data-driven diabetes care.

Research Unit

Metabolic-Research Unit, SCB Medical College, integrates postgraduate residents into registry projects and quality-improvement cycles.

Research Awards & Recognition

Recognition for research, academic excellence, and diabetes-focused service.

2018

Young Achievers Award

NCCD Kolkata

2014

DMDSC Honour

Dr Mohan's Diabetes Speciality Centre

2024 & 2025

Times Health ICON Odisha

Research & Academic Excellence

Data Ethics & Compliance

Research governance built around ICMR-GCP standards.

All studies adhere to ICMR-GCP standards, with protocol approval from the SCB Institutional Ethics Committee and registration on CTRI / ClinicalTrials.gov. Patient data are de-identified and stored on encrypted servers.

Last updated 05 July 2026. Content compiled from PubMed, ResearchGate, clinical-trial registries, and society publications.